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In vertebrates, the Rho family of GTPases is made of 20 members which regulate a variety of cellular functions, including actin cytoskeleton
dynamics, cell adhesion and motility, cell growth and survival, gene transcription and membrane trafficking. To get a comprehensive view of Rho
implication in physiological epithelial–mesenchymal transition, we carried out an in situ hybridization-based screen to identify Rho members
expressed in Xenopus neural crest cells, in which we previously reported RhoB expression at the migrating stage. In the present study, we identify
RhoV as an early expressed neural crest marker and provide evidence that its activity is essential for neural crest cell induction. RhoV mRNA is
maternally expressed and accumulates shortly after gastrulation in the neural crest forming region. Using antisense morpholino injection, we show
that at neurula stages, RhoV depletion impairs expression of the neural crest markers Sox9, Slug or Twist but has no effect on Snail induction. At
the tailbud stage, RhoV knockdown causes a dramatic loss of cranial neural crest derived structures. All these defects are rescued by ectopic wild-
type RhoV, whose overexpression on its own expands the neural crest territory. Our findings disclose an unprecedented Rho function in pathways
that control neural crest cells specification.
© 2007 Elsevier Inc. All rights reserved.Keywords: Rho GTPases; RhoV; Cranial neural crest; Specification; XenopusIntroduction
Rho GTPases act as molecular switches that play essential
roles in basic cellular functions such as cell proliferation,
differentiation, adhesion, motility or apoptosis (Etienne-Manne-
ville and Hall, 2002; Hall, 2005; Wennerberg and Der, 2004).
Like most other Ras-like members, Rho GTPases cycle between
an inactive GDP-bound state and an active GTP-bound state. The
activity switch is tightly regulated by the auxiliary proteinsGEFs,
GAPs and GDIs (Rossman et al., 2005; Van Aelst and D'Souza-
Schorey, 1997). Once activated, Rho GTPases interact with
specific downstream effectors and elicit a variety of intracellular
responses. In vertebrates, the Rho family is made of 20 members,⁎ Corresponding author. Fax: +33 4 67521559.
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doi:10.1016/j.ydbio.2007.07.031of which RhoA-C, Rac, Cdc42, RhoUV and RhoBTB were
already present in early Coelomates (Boureux et al., 2007). Most
functional data on the Rho family have been gained from studies
on RhoA, Rac and Cdc42, and largely pertained to the control of
F-actin cytoskeleton dynamics in response to the binding of
extracellular ligands to their membrane receptors (Jaffe and Hall,
2005). RhoA activation increases cell contraction whereas Rac
and Cdc42 promote cell plasticity through the production of
membrane protrusions. Rho activities have thus major outcomes
on cell properties, including shape, contraction, polarity and
intracellular trafficking (Etienne-Manneville and Hall, 2002;
Hall, 2005; Vignal et al., 2002; Wherlock and Mellor, 2002). In
addition to their roles on F-actin dynamics, Rho members also
control gene transcription, cell cycle entry and cell survival
through the activation of kinase cascades such as the JNK and
p38 MAP kinases (Etienne-Manneville and Hall, 2002; Fort,
1999; Jaffe and Hall, 2002; Ridley, 2001).
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more recently been investigated in embryonic development,
during which coordinated cell movements and migrations
massively occur and require changes in cell position, polarity,
shape and interaction with neighboring cells and the micro-
environment. In Drosophila, Rho, Rac and Cdc42 are required
for syncitium cellularization, gastrulation, planar cell polarity,
dorsal closure or neural development (Settleman, 1999, 2001).
In vertebrates, Rho pathways participate in gastrulation and
neurulation, two major and complex developmental processes
of early embryogenesis. Gastrulation is a step that involves the
coordinated regulation of cell polarity, movement and adhesion
and during which the basic body plan is set up. Convergent
Extension (CE) movements are the main driving forces for this
process, which results in intercalation of dorsal polarized
mesodermal cells toward the midline thereby inducing exten-
sion of the anteroposterior axis (Shih and Keller, 1992;
Wallingford et al., 2002). Recent studies in the Xenopus
embryo have revealed key roles of RhoA, Rac1, Cdc42 and
their effectors in regulating cell shape, polarity, protrusive and
adhesive properties during CE movements (Choi and Han,
2002; Faure et al., 2005; Habas et al., 2001, 2003; Tahinci and
Symes, 2003) although the molecular mechanisms that underlie
CE movement remain to be fully understood. In mouse, Rac1
and Cdc42 are required for the formation of the three germ
layers before or during gastrulation (Chen et al., 2000; Sugihara
et al., 1998).
The specification of neural crest cells and their migration
throughout the embryo at neurula stages is probably the most
dramatic morphogenetic event in vertebrate embryogenesis
(Erickson and Perris, 1993). The neural crest constitutes a
multipotent cell population that differentiates from the ectoderm
at the boundary of the neural plate, shortly after the induction of
the nervous system. Neural crest specification requires Wnt,
BMP and FGF signalings emanating from the surrounding
tissues and is initiated by the expression of transcription factors
of the bHLH, Snail and Sox families (Barembaum and Bronner-
Fraser, 2005; Hong and Saint-Jeannet, 2005; Steventon et al.,
2005). Following specification and concomitant with neural
tube closure, neural crest cells undergo an Epithelial–Mesench-
ymal Transition (EMT): neural crest cells delaminate from the
neural fold, migrate throughout the embryo and give rise to a
broad range of derivatives, including pigment cells, craniofacial
skeleton, connective tissues, neurons and glia of the peripheral
nervous system (LaBonne and Bronner-Fraser, 1999; Le
Douarin and Dupin, 2003). Given the dramatic changes in
neural crest cell adhesive properties (Duband et al., 1995), Rho
GTPases have been proposed to participate at one or the other
step of EMT. This is indeed the case for RhoA, RhoB or RhoC,
whose inhibition by C3 exotoxin prevented the delamination ofFig. 1. Xenopus RhoV protein sequence analysis and kinetics of mRNA levels. (A)
sequence. Positions identical to Xenopus RhoVa are in grey, semi-conserved po
(B) Similarity tree of Human (Hs) and X. laevis (Xl) RhoVand RhoU sequences. Cd
nodes are shown. Scale bar: 10% divergence. (C) Kinetics of RhoVmRNA expression
the indicated stages according to Nieuwkoop and Faber (1967). Ornithine decarbox
contamination, a control RT-PCR was done without reverse transcriptase (−RT).neural crest cells from chick neural tube explants (Liu and
Jessell, 1998).
To get a more comprehensive view of the implication of
the Rho family in neural crest development, we have isolated
cDNAs to all Xenopus laevis Rho members and initiated
analysis of their spatio-temporal expression during gastrula
and neurula stages. We recently showed that, at variance with
chick, RhoB is expressed in migrating neural crest cells but
not at the specification stage in X. laevis (Vignal et al.,
2007). In the present study, we focused on RhoV, one of the
eldest Rho members. Also misleadingly designed as Chp for
Cdc42 homologous protein (Aronheim et al., 1998), RhoV
delineates with RhoU a distinct Rho cluster equally distantly
related to Rac and Cdc42 (Boureux et al., 2007). RhoV was
initially identified as a protein interacting with the regulatory
domain of the PAK2 kinase (Aronheim et al., 1998; Sorokina
and Chernoff, 2005). Activated RhoV stimulates the JNK
pathway and triggers the formation of small lamellipodia and
focal adhesions (Aronheim et al., 1998; Aspenstrom et al.,
2004; Sorokina and Chernoff, 2005). However, unlike
classical Rho members, RhoV activity depends on palmitoy-
lation for association with cellular membranes, is insensitive
to RhoGDI and exhibits an autonomous transforming activity
(Chenette et al., 2005, 2006).
We show here that RhoV mRNA is expressed maternally in
Xenopus embryos and accumulates shortly after gastrulation in
the prospective neural crest-forming region, at the lateral edges
of the neural plate. RhoV induction coincides with that of Snail,
the earliest bona fide neural crest specific expressed gene
(Aybar et al., 2003; Essex et al., 1993; Linker et al., 2000;
Mayor et al., 1995). However, RhoVexpression is transient and
no longer detected in migrating neural crest cells. Functional
analyses using both gain and loss of RhoV function support a
pivotal and unexpected role for a Rho member in neural crest
cells specification.
Material and methods
Embryo manipulation
X. laevis embryos were obtained by in vitro fertilization, grown as
previously described (Faure et al., 2000) and staged according to Nieuwkoop
and Faber (1967).
Isolation of Xenopus RhoV and DNA constructs
To isolate X. laevis RhoV homologue, we performed blast searches in
expressed sequence tag (EST) database using rat RhoVas query (Chp, accession
number AF097887.1). Highest E-values obtained (4e−91 and 7e−91) were
found for BC077840 and BC078037.1 sequences, referred to as XRhoVa and
XRhoVb. XRhoVa cDNA was obtained by RT-PCR on stage 10 mRNA using
specific primers (forward primer 5′-CCGAAT TCGGCAGATACAAAATGCAlignment of X. laevis (Xl), human (Hs) and rat (Rr) RhoV and RhoU proteins
sitions are in black and non-conserved positions are in shaded background.
c42, Rac1 and RhoAwere used as outgroups. Only bootstrap values for internal
. Semi-quantitative RT-PCR analysis was performed on whole embryo mRNA at
ylase (ODC) was used as an internal control. To check for the absence of DNA
116 L. Guémar et al. / Developmental Biology 310 (2007) 113–128CAC CTC AAG TGATG; reverse primer 5′-CCC TCG AGC CCT TGT GGT
CGT CAT TC-3′; 56 °C annealing temperature and 30 cycles). XRhoVa ORF
was cloned into the EcoRI/XhoI sites of the pCS2+ vector (pCS2-RhoV) and
checked on an ABI310 automatic sequencer (Perkin-Elmer, Foster City, USA).
The T50N mutated version of RhoV (pCS2 T50N-RhoV) was generated by site-
directed mutagenesis (Stratagene, La Jolla, USA), using the following primers
(forward primer: 5′-GGA GCA GTG GGC AAG AAT AGC CTG GTG ATCAGC-3′ and reverse primer: 5′-GCT GAT CAC CAG GCT ATT CTT GCC
CAC TGC TCC-3′).
RT-PCR analyses
RhoV RT-PCR analysis were performed as previously reported (Vignal et
al., 2007) using specific RhoV primers (forward primer 5′-CCG AAT TCG
117L. Guémar et al. / Developmental Biology 310 (2007) 113–128GCA GATACA AAATGC CAC CTC AAG TGATG; reverse primer 5′-CCC
TCG AGC CCT TGT GGT CGT CAT TC-3′; 56 °C annealing temperature and
25 cycles). Ornithine decarboxylase (ODC) RT-PCR (56 °C annealing
temperature and 25 cycles) was used as an internal control (Agius et al., 2000).
Morpholino assays
Morpholino antisense oligonucleotides (MO) were obtained from Gene
Tools (Philomat, USA). RhoV-MO and RhoU-MO were designed to target the
translation–initiation site of RhoV and RhoU, respectively (Fig. 5A). A
randomized antisense oligo (Ctrl-MO) was used as a control sequence. MOs
were injected into a single cell of a two-cell stage embryo, at the same
concentration (20 ng per embryo). Rho-GFP fusion constructs were performed
as follows: XRhoV and XRhoU ORFs were amplified (RhoV Forward GGA
AGA AAT ATT TCT GCT TTG TTC AGT CGA CGG; RhoV Reverse CCG
TCG ACT GAA CAA AGC AGA AAT ATT TCT TCC; RhoU Forward GG
AAAAAG TAT GTG TGT GTC CAG TCGACGG; RhoU Reverse CCG TCG
ACT GGA CAC ACA CAT ACT TTT TCC) and cloned into EcoRI/SalI
cleaved pEGFP N1 (Clontech, Mountain View, USA). pCS2-RhoV-GFP and
pCS2-RhoU-GFP constructs (GFP fused at GTPase C-termini) were generated
by transferring GFP fusions into pCS2. pCS2-GFP-RhoV (GFP fused at RhoV
N-terminus) was generated by ligation of RhoV ORF into EcoRI/XhoI cleaved
pEGFP C3 (Clontech) then transferring the NheI/XbaI GFP-RhoV fragment into
XbaI-cleaved pCS2. Inhibition efficiency and specificity of RhoV-MO and
RhoU-MO were evaluated as follows: embryos were injected with mRNA
encoding RhoV-GFP, RhoU-GFP or GFP-RhoV alone or in combination with
RhoV-MO, RhoU-MO or Ctrl-MO. Embryos were collected at stage 18, lysed
and analyzed by Western blot using anti-GFP antibodies.
In vitro transcription
Synthetic-capped mRNAs were generated using the mMessage mMachine
kit (Ambion, Austin, USA) as listed bellow: pCS2-RhoV (NotI, Sp6), pCS2
T50N-RhoV (NotI, Sp6), pCS2-RhoV-GFP (NotI, Sp6), pCS2-RhoU-GFP
(NotI, Sp6), pCS2-GFP-RhoV (NotI, Sp6), pSP64T Gsk3β (Saint-Jeannet et al.,
1997; EcoRI, Sp6), pCS2-RhoB (Vignal et al., 2007; NsiI, Sp6).
Western blot analyses
Western blot analyses were performed as previously described (Faure et al.,
2005). Whole embryos were homogenized in lysis buffer (10 μl per embryo of
20mMTris, pH 8, 50mMNaCl, 50mMNaF, 10mMβ-glycerophosphate, 2mM
EDTA, 1% NP 40, 20 mM aprotinin, 0.75 mM PMSF). Lysates were centrifuged
at 14,000×g for 10 min at 4 °C; supernatants were analyzed on 10% SDS
polyacrylamide gels (SDS-PAGE) and transferred to nitrocellulose membranes
(Protran, Victoria, Australia). Membranes were blocked at room temperature for
1 h in 2%milk in TBST (10 mM Tris, pH 8, 150 mMNaCl, 0.2% Tween 20) and
incubated overnight at 4 °Cwith anti-GFP antibody (RocheDiagnostics, USA, 1/
1000). After several washes in TBST, membranes were incubated for 1 h at room
temperature with peroxidase-conjugated secondary antibody (GE Healthcare,Fig. 2. Developmental RhoV mRNA expression. In situ hybridization of stages 10.5 a
RhoV is expressed in the dorsal marginal zone. Xbra expression at stage 11 is shown f
C′ are sagittal hemisections across the transverse lines in panels B and C, respectivel
detected in the involuting dorsal mesodermal cells (idm). At the end of gastrulation (s
above the blastopore (bl). From stage 12, a second domain of expression is detected at
positive neural crest territory (H, black arrowheads). Shown are vegetal views of stag
J) and RhoV/Sox9 (L and M) double in situ hybridization analyses. Shown in panels J
Single Sox9 in situ hybridization is shown for comparison. At early neurula stages (1
border, covering both the lateral (black arrowheads) and the anterior (white arrowhead
(R) is expressed in the anterior (white arrowhead) neural plate border and in the media
R′ are sagittal hemisections across the transverse lines in panels Q and R. (S) RhoV/
medial (red arrowhead) and lateral (black arrow) neural crests. (T) Control Sox9 in sit
and highly in the lateral (black arrow) neural crest and in the otic placodes (green arro
expressed in the otic placodes stained by Sox9. At the onset of neural tube closure (
From stage 22 (X, dorsal view, anterior towards the top; Y, lateral view, anterior towLittle Chalfont, UK), washed in TBST and developed with chemiluminescence
reagents (PerkinElmer, Life Sciences) as described by the manufacturer.
Lineage tracing
Embryos were co-injected with β-galactosidase (β-gal) mRNA (200 pg). At
the appropriate stages, embryos were fixed for 30 min at room temperature in
MEMFA (0.1 M MOPS, pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7%
formaldehyde), washed three times in PBS for 10 min each and processed for β-
galactosidase activity in staining solution (10 mM K3Fe(CN)6, 10 mM k4Fe
(CN)6, 2 mM MgCl2, in PBS at pH 7.4) with 5-bromo-4-chloro-3-indolyl-β-D
galactosidase (X-Gal; Promega, Madison, USA) for blue color or with 6-chloro-
3-indolyl-β-D galactosidase (Red-Gal; Research Organics, Cleveland, USA) for
red color.
Whole-mount in situ hybridization
In situ hybridizations were performed essentially as described previously
(Harland, 1991) except that BM purple (Roche Diagnostics, Pleasanton, USA)
was used as a chromogenic substrate for single in situ analyses. DIG-labeled
antisense probes (Roche Diagnostics, Pleasanton, USA) were generated as listed
bellow: RhoV (HindIII, T7), Slug (Mayor et al., 1995), Snail (Essex et al.,
1993), Sox9 (Spokony et al., 2002), Sox10 (Aoki et al., 2003), Twist (Hopwood
et al., 1989), Xbra (Smith et al., 1991), Sox2 (Nitta et al., 2006) and MyoD
(Della Gaspera et al., 2006). Double in situ hybridization analyses were
performed as previously reported (Vignal et al., 2007).
Proliferation and cartilage staining
RhoV-MO- or Ctrl-MO-injected embryos were fixed at the appropriate
stages in MEMFA and the β-galactosidase activity was revealed using the 5-
bromo-4-chloro-3-indolyl-β-D galactosidase (X-Gal; Promega) as a substrate.
Proliferation was estimated by phospho-histone H3 detection, as previously
described (Saka and Smith, 2001). Anti-phospho-histone H3 antibody (Upstate
Biotechnology, Millipore, Billerica, USA) was used at 5 μg/ml; anti-rabbit-
conjugated with peroxidase was used at a concentration of 1/1000 and detected
using the Fast 3,3′-Diaminobenzidine Tablet sets (Sigma-Aldrich). For cartilage
staining, Alcian Blue staining was performed on stage 45 as previously
described (Bellmeyer et al., 2003).Results
RhoV identification in X. laevis and early developmental
expression
To identify RhoV orthologues in X. laevis, we performed
Tblastn searches in expressed sequence tag (EST) database
using rat RhoV/Chp as query. We identified two sequencesnd 11 (A, B) (vegetal views, dorsal towards the top). At the onset of gastrulation,
or comparison (C, vegetal view, dorsal towards the top). Shown in panels B′ and
y (dorsal side on the right). At mid-gastrula stages, RhoVand Xbra stainings are
tages 12 and 12.5, D–G), RhoV mRNA localizes at the dorsal side of the embryo
the lateral edges of the neural plate (black arrowheads), as compared with Snail-
e 12 (D) and stage 12.5 (E), dorsal views of stage 12.5 (F–H). RhoV/Snail (I and
and M are magnified views of the area boxed respectively in panels I and L. (K)
3–14) (N, P), RhoV mRNA appears as an arc surrounding the entire neural plate
) neural plate border as observed for Snail (O). At stage 15, RhoV (Q) like Snail
l (red arrowhead) and lateral (black arrow) neural crests. Shown in panels Q′ and
Snail double in situ hybridization analysis. Like Snail, RhoV is expressed in the
u hybridization is shown for comparison. Sox9 is expressed faintly in the medial
w). (U) RhoV/Sox9 double in situ hybridization analysis. Note that RhoV is not
stage 19, V), expression of RhoV is down-regulated in the neural crest territory.
ards the right), RhoV expression is no longer detected in the neural crest.
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shared 76% similarity with those of rat and human RhoV
proteins (Fig. 1A). Compared to X. laevis RhoU, the closest
RhoV relative (Daigo et al., 2004), the similarity dropped to
61%. Phylogenetic analyses confirmed RhoV orthology (Fig.
1B). The deduced proteins, referred to as Xenopus RhoVa and
RhoVb, differ by six amino acid positions, of which four are
conservative. Since RhoV is unique in Xenopus tropicalis
(Boureux et al., 2007), the two X. laevis RhoV genes probably
originated when tetraploidization took place. Xenopus RhoVa
and RhoVb ORFs show only 5% divergence and 73% of the
nucleotide substitutions are silent ones, which suggests that
both genes are under purifying selection.
We first examined by semi-quantitative RT-PCR the kinetics
of RhoV gene expression at different stages of Xenopus
embryonic development (Fig. 1C). RhoV mRNA was detected
at stage 5, before the mid-blastula transition (MBT), indicating
that RhoV is maternally expressed. Then, RhoV expression
started increasing from gastrulation and was detected through
later developmental stages until stage 21 after which RhoV
mRNA declined to undetectable levels.
RhoV is an early marker of the developing neural crest
To analyze the spatial expression pattern of RhoV, we
performed whole-mount in situ hybridization on a variety of
embryonic stages. RhoV transcripts were detected first in the
dorsal marginal zone at early gastrula (Fig. 2, panels a and b)
and remained localized all along gastrulation on the dorsal
side above the blastopore (Fig. 2, panels d–g). Stage 11Fig. 3. Canonical Wnt signaling regulates expression of RhoV in the neural crest. (A)
DNA encoding mouse Wnt-1. DNAwas used instead of mRNA to reduce expression
mRNA encoding human GSK3β. At this level, expression of GSK3β has no effect
analyzed by whole-mount in situ hybridization for the neural crest markers Sox9 (a)
laterally expanded upon canonical-Wnt signaling activation, and conversely down-
mRNAwas co-injected to visualize the injected side (red staining).embryo hemisections revealed similar RhoV and Xbra
stainings in the involuting dorsal mesodermal cells (Fig. 2,
compare panels b, b′ to panels c, c′). From stage 12, RhoV
stained a second region lateral to the prospective neural plate
(Fig. 2, see black arrowheads in panels d to g). This region
corresponds to the prospective neural crest domain, as shown
by RhoV/Snail and RhoV/Sox9 double in situ hybridization
analyses (Fig. 2, panels i, j and l, m). A closer comparison of
RhoV and Snail stainings showed that RhoV expression, like
Sox9, is restricted to the most anterior region of the Snail-
expressing domain (Fig. 2, compare panels g, h and k; see also
panels i, j and l, m). At the early neurula stage, we detected
RhoV expression at the lateral plate borders (Fig. 2, panels n
and p). Like Snail, RhoV stained the anterior border of the
neural plate (Fig. 2, compare panel o with panels n and p). At
stage 15, RhoV was expressed both in the medial (Fig. 2,
compare panels q with r and cross sections q′ with r′ for RhoV
and Snail respectively) and lateral (Fig. 2, compare panels q
with r and t for RhoV, Snail and Sox9 stainings, respectively)
neural crest. RhoV was preferentially expressed in the most
lateral side of the Snail and Sox9-expressing domains, as
shown by RhoV/Snail and RhoV/Sox9 double in situ
hybridizations (Fig. 2, panels s and u). As neurulation
proceeded, RhoV remained exclusively expressed in the
neural crest regions borders (Fig. 2, panel v). RhoV expression
started decreasing at the onset of neural tube closure (Fig. 2,
panels w and x) and was no longer detected at the tadpole
stage (Fig. 2, panel y), in agreement with RT-PCR data (Fig.
1C). Our data show that RhoV belongs to the earliest
expressed group of neural crest markers.Two-cell stage embryos were injected in one blastomere with 100 pg of plasmid
and avoid axis duplication. (B) Alternately, embryos were injected with 1 ng of
on mesoderm development (data not shown). At neurula stages, embryos were
, Snail (b) and RhoV (c). Expression of all neural crest markers and RhoV was
regulated upon Wnt inhibition. In all panels, the lineage tracer β-galactosidase
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signaling
In vertebrates, neural crest induction is dependent on
multiple developmental signals, including BMPs, FGF and
Wnt-class factors (Huang and Saint-Jeannet, 2004). In parti-
cular, the canonical Wnt pathway is needed for neural crest
induction, while the non-canonical Wnt pathway is required for
migration (De Calisto et al., 2005). In Xenopus, production of
neural crest progenitors was shown to be enhanced upon
canonical Wnt activation and conversely reduced upon inhibi-
tion (Bang et al., 1999; Chang and Hemmati-Brivanlou, 1998;
Deardorff et al., 2001; LaBonne and Bronner-Fraser, 1998;
Saint-Jeannet et al., 1997). To examine whether RhoV
expression is sensitive to the same pathway, embryos were
co-injected at the two-cell stage with nuclear β-galactosidase
mRNA (200 pg) as a lineage tracer and either a Wnt-1
expression vector (100 pg) to activate the canonical Wnt
signaling or Gsk3β mRNA (1 ng) to inhibit it. As expected,
ectopic Wnt-1 expression induced a lateral expansion of the
cranial neural crest territory, as illustrated by in situ hybridiza-
tion of Sox9 and Snail (Fig. 3A, panels a and b; see also Luo et
al., 2003; Saint-Jeannet et al., 1997). A similar lateral expansion
was observed for RhoV expression (Fig. 3A, panel c). In
contrast, Wnt inhibition upon Gsk3β overexpression reduced
Snail and Sox9 stainings (Fig. 3B, panels a and b) as well as that
of RhoV (Fig. 3B, panel c). These data indicate that like Snail
and Sox9, RhoVexpression is under the control of the canonical
Wnt signaling pathway.
RhoV extinction differentially affects neural crest marker
expression
To address the role of RhoV in neural crest cell
development, we used two loss-of-function approaches. First,
we examined the effect of the T50N-RhoV mutant, analogous
to the T17N mutants shown to act as dominant negative in
other Ras-like GTPase signalings (Marshall, 1996). Embryos
were co-injected at the two-cell stage with T50N-RhoV mRNA
(1 ng) and the nuclear β-galactosidase mRNA (200 pg) as a
lineage tracer. Either side of the T50N-RhoV-injected embryos
developed normally during the early stages. However, at
neurula, in situ hybridization analyses showed a significantFig. 4. The loss of RhoV differentially affects the induction of neural crest markers. E
RhoV mRNA and analyzed at the neurula stage for Sox9 (a), Slug (b) and Snail (c) e
identify the injected side (red staining), oriented to the right in all panels. The loss of R
embryo while Snail (c) was not affected.reduction of Sox9 (68%, n=95) and Slug (72%, n=68)
stainings in the injected side compared with the uninjected side
(Fig. 4, panels a and b). Unexpectedly, we observed no
reduction in Snail staining (n=83) (Fig. 4, panel c). To confirm
the T50N-RhoV effect, we next used a morpholino antisense
oligonucleotide directed against both RhoV mRNA initiator
sequences (Fig. 5A). As a prerequisite, we checked by co-
injection experiments that RhoV-MO efficiently blocked the
translation of a RhoV-GFP fusion mRNA, whereas a control
MO (Ctrl-MO) or a morpholino directed against RhoU (the
closest RhoV relative) had no effect (Fig. 5B). RhoV-MO
appeared specific since it did not affect the translation of a
RhoU-GFP fusion mRNA, whereas this latter was efficiently
blocked by RhoU-MO (Fig. 5C). Co-injection of RhoV-MO
(20 ng) and the nuclear β-galactosidase mRNA (200 pg) at
two-cell stage did not impair early development, as observed
for T50N-RhoV mRNA or control-MO injection. As shown in
Fig. 5D, RhoV depletion did not change the expression pattern
of Xbra (Fig. 5D, panels a–d) or MyoD (Fig. 5D, panels e and
f), suggesting that RhoV activity is not critical for mesodermal
development during early embryogenesis. At the neurula stage,
RhoV-MO, like T50N-RhoV, had no effect on Snail expression
(n=100) (Fig. 5E, panel g) but induced a significant reduction
of Sox9 (86%, n=250), Slug (81%, n=110), Sox10 (75%
n=90) and Twist (61%, n=50) (Fig. 5E, panels b, d, e and f)
expression. The effects of RhoV-MO on neural crest induction
were efficiently rescued by GFP-RhoV (100 pg) (insensitive to
RhoV-MO, Fig. 5F) or GFP-RhoU (100 pg) (80%, n=78;
72%, n=70, respectively, Fig. 5G, panels b and c). Note that
no endogenous RhoU is detected in neural crest cells at this
early stage (data not shown). In contrast, at the same amount,
RhoB was unable to rescue the RhoV-MO phenotype (n=80)
(Fig. 5G, d).
RhoV-deficient embryos develop abnormal craniofacial
skeletons
The preceding data disclosed a particular situation in which
Snail is still expressed in the neural crest territory, whereas other
critical genes are down-regulated. We next evaluated the effect
of RhoV depletion on embryos at later neurula stages. As
illustrated in Fig. 6A, injection of RhoV-MO (20 ng) at the two-
cell stage led to a marked reduction of Sox9 and Twistmbryos were injected in one blastomere at the two-cell stage with 1 ng of T50N-
xpression. β-galactosidase mRNAwas co-injected with T50N-RhoV mRNA to
hoV strongly reduced Sox9 (a) and Slug (b) expression on the injected side of the
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Fig. 5. Early neural crest marker expression is impaired in RhoV-depleted embryos. (A) Comparison of RhoVa and RhoVb mRNA initiator regions. Shown in red are
the nucleotides that differ between the two sequences. RhoV-MOwas designed to target the sequence underlined in black. (B) Western blot analysis of lysates prepared
from control embryos (Uninjected) or embryos expressing the RhoV-GFP fusion alone (noMO) or co-injected with 20 ng per embryo of control MO (Ctrl-MO), RhoV-
MO or RhoU-MO. Arrow indicates the position of the RhoV-GFP fusion. Only RhoV-MO inhibited RhoV-GFP translation. (C) Western Blot analysis of lysates
prepared from control embryos (Uninjected), or embryos expressing the RhoU-GFP fusion alone (no MO) or co-injected with 20 ng per embryo of control MO (Ctrl-
MO), RhoV-MO or RhoU-MO. Arrow indicates the position of the RhoV-GFP fusion. RhoV-MO does not inhibit RhoU-GFP translation. (D) Xbra and MyoD in situ
hybridization analyses. Embryos were injected in one cell of two-cell stage embryo with 20 ng of RhoV-MO or control MO. β-galactosidase mRNAwas co-injected to
identify the injected side (red staining). Embryos were harvested at gastrula (a–d) and neurula stages (e, f) and analyzed respectively for Xbra and MyoD stainings.
Shown are vegetal (a, c) or dorso-vegetal (b, d) or lateral (e, f) views. Control non-injected side (e) and RhoV-MO-injected side (f) of the same embryo. (E) In situ
hybridization of early neurula stage embryos injected in one cell of two cell-stage embryos with 20 ng of control MO (Ctrl-MO) or RhoV-MO. Dorsal views, anterior to
the top. RhoV depletion inhibits or strongly reduces the expression of the early neural crest markers Sox9 (b), Slug (d), Sox10 (e) and Twist (f) but has little effect on
Snail expression (g). Note that depletion of RhoValso reduces the expression of Sox9 in the otic placodes (b). Injection of Ctrl-MO has no effect on Sox9 (a) or Slug
(c). (F) Western Blot analysis of lysates from control embryos (Uninjected) or embryos expressing a RhoV-GFP fusion alone (no MO) or in combination with 20 ng of
control MO (Ctrl-MO) or RhoV-MO, and embryos expressing a GFP-RhoV fusion alone (no MO) or in combination with 20 ng of RhoV-MO. Arrow indicates the
position of GFP-RhoVand RhoV-GFP. GFP-RhoVmRNA is insensitive to RhoV-MO. (G) The loss of Sox9 expression upon RhoV depletion is rescued by injection of
mRNA (100 pg) encoding GFP-RhoVor the same amount of its closely relative GFP-RhoU. The translation of GFP-Rho fusion proteins is insensitive to RhoV-MO
(see panels C and F). Note that expression of RhoB is not able to restore Sox9 expression. In all cases, the injected side is oriented to the right (red staining is from the
lineage tracer β-Gal).
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Fig. 6. RhoV depletion results in a loss of neural crest derivatives. (A) In situ hybridization of stage 25 embryos injected in one cell of two cell-stage embryos with
20 ng of RhoV-MO. Lateral views, anterior to the left. Shown are Sox9 (a, b) and Twist (c, d) stainings on uninjected control sides (a, c) and on RhoV-MO-injected
sides (b, d). RhoV depletion strongly reduces Sox9 and Twist expression in the migrating neural crest (black arrow) while Sox9 expression in the otic placode was
less affected. (B) RhoV-depleted embryos develop abnormal cranio facial skeletons. Embryos were injected in one cell of two-cell stage embryo with 20 ng of
control MO (Ctrl-MO) or RhoV-MO as indicated and fixed at stage 45. The injected side is on the right, as monitored by the co-injected β-galactosidase mRNA
lineage tracer (red staining). Shown are one Ctrl-MO-injected embryo (a–c) and two RhoV-MO-injected embryos (e–g and i–k) representative of the observed
skeletal defects. (a, b, e, f, i, j) Dorsal views; (c, g, k) ventral views. Skeletal structures from stage 45 tadpoles were stained with Alcian blue on flat-mount embryos
(d, h, l). Shown are the normal pattern of skeletal elements in a Ctrl-MO-injected embryo (d) and the abnormal skeletal structures in Rho-depleted embryos (h and l).
(m) Drawing of ventral cranial cartilages modified from Sadaghiani and Thiebaud (1987) and Spokony et al. (2002). Me, Meckel's; Ce, cerathoyal; Ba, basihyal; Br,
branchial/gill. Arrows in panels d, h and i use the same color code as in panel m. The most severe phenotype (e–h) is a complete loss of the Meckel's (red arrow),
the cerathoyal (orange) and the branchial (green and purple arrows) cartilages, whereas these structures are only reduced in the attenuated phenotype (i–l). (C)
RhoV-depleted embryos show expanded neural plate. Two-cell stage embryos were injected in one cell with 20 ng of control-MO (Ctrl-MO) (a, c, e) or RhoV-MO
(b, d, f). At early neurula stage, embryos were processed for single Sox9 and Sox2 (a–d, respectively) or double Snail/Sox2 (e, f) in situ hybridization analyses.
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Fig. 6 (continued).
123L. Guémar et al. / Developmental Biology 310 (2007) 113–128expression in the three branchial arches at stage 25 (compare
panels a to b and panels c to d), indicating a long term effect of
RhoV silencing on neural crest development. We then
addressed the effects on the formation of neural crest
derivatives, which can be easily evaluated at stage 45. Cranial
structures were clearly affected on the RhoV-MO-injected side
compared with the uninjected side or with embryos injected
with control MO (Ctrl-MO) (Fig. 6B; compare panels a–c to
panels e–g and panels i–k). Since neural crest cells of the
branchial arches form the cartilages of the embryonic facial
skeleton, we stained RhoV-MO and control MO-injected
embryos with the cartilage-specific alcian blue dye. 74% of
RhoV-MO-injected embryos showed defects, ranging from a
reduction of cranial structures such as Meckel's, branchial and
cerathoyal cartilages (52%, n=120) (Fig. 6B, compare panels d
to l) to a total loss of cranial cartilages (22%, n=120) (compare
panels d to h). In contrast, neither the anterior to posterior
patterning nor the differentiation of the trunk neural crest cells
seemed to be disturbed in the RhoV-MO-injected tadpole
embryos (Fig. 6B, compare panels a, e and i). These results
indicate that RhoV depletion specifically affects the formation
of the neural crest precursors that give rise to the facial skeleton.
RhoV silencing affects neural crest cells differentiation
Several mechanisms could account for the loss of neural
crest markers and cranial derivatives in RhoV-MO-injectedembryos. RhoV may play a role in promoting proliferation/and
or survival of the neural crest precursors pool. However,
whole-mount embryo TUNEL staining showed that RhoV
depletion does not significantly affect apoptosis in the neural
crest cell territory (data not shown), in consistency with the
sustained expression of Snail. We then addressed the
possibility that RhoV may influence neural crest cells fate
from the early ectoderm. Indeed, neural crest cells arise at the
neural plate border with non-neural ectoderm, and the neural
crest reduction observed in RhoV-depleted embryos might be
associated with an expansion of the surrounding tissues (i.e.
epidermis and CNS). We thus examined RhoV-MO-injected
embryos for the expression of the pan neural marker Sox2,
which revealed a marked increase of Sox2 territory on the
RhoV-MO-injected side compared with control-MO (Fig. 6C,
compare panels c to d). Since Snail remained expressed upon
RhoV depletion (Fig. 5E, panel g), we examined by double in
situ hybridization analysis whether the expanded Sox2 domain
overlapped the Snail territory. As shown in Fig. 6C (compare
panels e to f), both stainings were distinct, the Snail territory
having shifted laterally at the border of the Sox2 domain. This
indicates that the depletion of RhoV has not modified the
neural crest cells fate. Taken together, these data rather suggest
that RhoV is involved in the progression of neural crest cells
differentiation.
RhoV overexpression induces the expansion of the neural crest
Having shown that RhoV depletion blocks neural crest cells
differentiation, we next asked whether wt-RhoVoverexpression
might conversely induce the expansion of the neural crest
domain. To this aim, two-cell stage embryos were injected with
wt-RhoV mRNA and examined at neurula stage for neural crest
marker expression. Wt-RhoV induced a marked expansion of
the domain expressing Snail (69%, n=50), Sox9 (76%,
n=110), Sox10 (70%, n=60) or Slug (68%, n=55) (Fig. 7A,
panels a–d) at early neurula stage. Conversely, we observed a
reduction of the domain expressing the neural plate marker
Sox2 (75%, n=89) (Fig. 7A, panel e). This phenotype was
observed reproducibly when 50–100 pg mRNA was injected.
Interestingly, at late neurula stage, forced expression of RhoV
led to an increase in Twist signal compared to the control side of
the same embryo (Fig. 7A, compare panels f to g) and neural
crest cells migrated as well-organized streams. Although the
formation of neural crest precursors at the lateral edges of the
neural plate has little dependence on cell proliferation
(Bellmeyer et al., 2003), forced expression of a Rho member
might affect cell proliferation, as previously shown in cultured
cell lines. We thus assessed cell proliferation by phospho-
histone H3 staining, which identifies cells undergoing mitosis.
As shown in Fig. 7B, we detected no significant staining
difference between the wt-RhoV-injected and the control sides
of the same embryo (panels a–c). To strengthen this observa-
tion, we incubated wt-RhoV-injected embryos with HUA, a cell
proliferation inhibitor mixture of hydroxyurea and aphidicolin
(Aybar et al., 2003). Although HUA treatment efficiently
blocked cell proliferation, as monitored by anti-phospho-
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panels a to b), it did not impaired neural crest expansion on wt-
RhoV-injected embryos, as visualized by Sox9 labeling (Fig.7C, compare panels c to d). We thus conclude that wt-RhoV
overexpression expands the neural crest domain independently
of cell proliferation.
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During the last decade, considerable progress has been made
toward the understanding of the molecular mechanisms that
control neural crest cells differentiation, in particular the
influence of Wnt, BMP and FGF signalings and the roles of
transcription factors of the c-Myc, Id, Snail and Sox families
(Barembaum and Bronner-Fraser, 2005; Hong and Saint-
Jeannet, 2005; Steventon et al., 2005). Given the pivotal effects
of Rho activities on basic cell properties, in particular
morphology, adhesion, migration and polarity, it had been
suspected that these proteins might participate in embryonic
development. Indeed, it was shown recently in Xenopus that
Rho proteins control convergent/extension cell movements
during gastrulation (Choi and Han, 2002; Habas et al., 2001,
2003; Tahinci and Symes, 2003). However, most studies had
focused so far on the roles of RhoA, Rac and Cdc42, the most
conserved and expressed members from lower eukaryotes to
mammals (Boureux et al., 2007) and little is known on the roles
of the other Rho members. In the present study, we show that
RhoV mRNA, encoding an unconventional Rho GTPase
member, is transiently expressed at late gastrula and during
the early steps of neural crest development in the Xenopus
embryo. Using gain and loss of function analyses, we provide
evidence that RhoV is an essential component of the pathways
that control cranial neural crest development.
RhoV is transiently expressed in early neural crest stages
RhoV is an early gene expressed in the neural crest forming
region from stage 12 (Fig. 2). This feature is not restricted to
Xenopus since RhoV is also expressed early in the neural
crest territory of the chick embryo (data not shown). In Xeno-
pus, RhoVexpression is first detected as an arc surrounding the
entire neural plate, a hallmark of the earliest neural crest genes
such as Snail (Aybar et al., 2003; Linker et al., 2000), whereas
later genes (Slug, Sox9, etc.) are expressed only in the lateral
neural crest territories (Linker et al., 2000; Spokony et al.,
2002). However, RhoV expression is not detected before stage
12, whereas Snail is expressed in the prospective neural crest
domain as soon as stage 11 (Aybar et al., 2003; Essex et al.,
1993; Linker et al., 2000; Mayor et al., 1995). This suggests
either that RhoV is induced after Snail or that it is expressed at a
too low level to be detected at earlier stages. This latter
hypothesis is supported by the low incidence of RhoV mRNAFig. 7. RhoVoverexpression expands the neural crest territory. (A) In situ hybridizatio
RhoV mRNA and the β-galactosidase mRNA lineage tracer. Sox9 (a), Sox10 (b), Slu
analysis on late neurula stage embryos. At early neurula stage, the ectopic expression
the domain stained by the neural plate marker Sox2 as indicated by black arrows. At la
the injected side (g) compared to the control side (f). (B) Expression of wt-RhoV does
with 100 ng of wt-RhoVand the β-galactosidase mRNA lineage tracer (red staining)
hybridization (a) or for anti-phospho-histone H3 staining by immunochemistry (b). β
view of the area boxed in panel b is shown in panel c. No significant difference wa
expansion of the neural crest territory induced by RhoV does not require cell prolife
RhoVmRNA and β-galactosidase mRNA as a tracer. At stage 11, control (a, b) and in
15. Injected embryos were processed for Sox9 in situ hybridization and control embr
HUA treatment (d), whereas it induced a 90% reduction in the number of mitotic cein mouse tissues (Boureux et al., 2007), which suggests that
RhoVactivity requires low levels of expression. At later neurula
stages, RhoV expression is detected in a subpopulation of cells
located at the most lateral side of the neural crest domain. The
pattern of RhoV is relatively unique compared to other Rho
members identified so far in the Xenopus embryo. Indeed, Rac1
and RhoB are both expressed in migrating but not in pre-
migratory neural crest (Lucas et al., 2002; Vignal et al., 2007),
while Cdc42 and RhoA seem to be ubiquitously expressed
(Choi and Han, 2002; Wunnenberg-Stapleton et al., 1999). Only
Rnd1 is expressed at the pre-migratory stage, although later than
RhoV (Wunnenberg-Stapleton et al., 1999; data not shown).
The molecular mechanisms by which RhoV is regulated
remain to be determined. We showed that RhoV expression in
the early ectoderm requires the canonical Wnt signaling
pathway. Indeed, forced Wnt pathway activation expands
RhoV expression while Wnt signaling inhibition impairs
RhoV mRNA accumulation (Fig. 3). This feature is shared by
most genes known to control neural crest formation, including
Sox9, Slug, Snail, Ap2α, Sox10 and c-Myc (Aoki et al., 2003;
Lee et al., 2004; Luo et al., 2003; Bellmeyer et al., 2003).
However, a feature peculiar to RhoV is its transient mRNA
expression, lost at the migrating stage. This raises issues on the
relative contributions of transcriptional and post-transcriptional
events on RhoV up-regulation at earlier neural crest stages. This
also suggests that the RhoV protein may have a short half-life,
like many proteins encoded by unstable mRNAs. Protein
degradation as a shut-off mechanism is consistent with the
unusual biochemical properties of this subclass of Rho proteins,
in particular their insensitivity to the negative regulator GDI
(Chenette et al., 2006).
RhoV is an essential regulator of neural crest induction
Neural crest formation is a complex multistep process, at the
onset of which expression of many transcription factors is
required at the neural plate border, including Snail, Slug, Ap2α,
Sox8, Sox9, Sox10, c-Myc and Id3 (Aoki et al., 2003; Aybar et
al., 2003; Essex et al., 1993; Honore et al., 2003; Kee and
Bronner-Fraser, 2005; LaBonne and Bronner-Fraser, 2000;
Light et al., 2005; Linker et al., 2000; O'Donnell et al., 2006;
Spokony et al., 2002). RhoV thus belongs to the same set of early
response genes, being expressed and required as early as stage
12 (Figs. 2 and 5). Interestingly, RhoV extinction differentially
affects the expression of early neural crest markers: Snailn analysis of neurula stage embryos injected at two-cell stage with 100 ng of wt-
g (c), Snail (d) and Sox2 (e) analysis on early neurula stage embryos. Twist (f, g)
of wt-RhoVenlarges the domain stained by all neural crest markers and reduces
te neurula stage, forced expression of RhoV led to an increase in Twist signal on
not affect cell proliferation. Two-cell stage embryos were co-injected in one cell
. At early neurula stage, injected embryos were processed either for Sox9 in situ
-galactosidase activity was revealed using Red-Gal (a) or X-Gal (b). A magnified
s observed in the number of mitotic cells in either side of the embryo. (C) The
ration. Two-cell stage embryos were co-injected in one cell with 100 ng of wt-
jected embryos (c, d) were treated (b, d) or not (a, c) with HUA and fixed at stage
yos for anti-phospho-histone staining H3. Sox9 expansion (c) is not affected by
lls (compare panel b with a).
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inhibited. Despite the sustained Snail expression, RhoV
depletion blocks neural crest cells development, as evidenced
by the marked reduction of cranial structures at the tailbud stage.
A similar situation was already reported for a dominant negative
mutant of Slug/Snail, whose expression prevented neural crest
formation (LaBonne and Bronner-Fraser, 2000) through inhibi-
tion of Sox9 and Slug but not of Snail expression (Lee et al.,
2004). The effects of deregulated RhoV expression are
independent of cell apoptosis or proliferation, and the level of
RhoVexpression negatively correlates with the size of the neural
plate territory, as evidenced by Snail and Sox2 mRNA stainings.
A role of RhoV in regulating the balance between neural and
neural crest fate is unlikely since Snail and Sox2 showed
disjunctive stainings in all experiments (Fig. 6). One possibility
could be that RhoV affects indirectly cell rearrangements
required for neural plate elongation and narrowing during neural
tube formation. Indeed, neural tube closure in Xenopus involves
medial migration, intercalation and convergent extension move-
ments of dorsal neural cells, driven by the monopolar medially
directed protrusive activity of neural crest cells (Davidson and
Keller, 1999). Accordingly, all events that block neural crest
development should be associated with failure of the neural plate
folding and thus with an increased Sox2 expression area. This is
consistent with previous data on Sox9, whose depletion
impaired neural crest development and inhibited the folding of
the neural plate (Spokony et al., 2002).
How does RhoV control neural crest specification?
It was suggested that Snail is one of the earliest genes
expressed in neural crest and its induction is a prerequisite for
Slug induction (Aybar et al., 2003). Our data show that RhoV
extinction impairs Slug but not Snail mRNA accumulation (Fig.
5E). The simplest hypothesis to our findings is that RhoV
activity is required for Snail to up-regulate downstream genes.
According to this scheme, RhoV depletion would not affect
Snail mRNA accumulation but prevent the downstream
cascade, whereas RhoV overexpression would increase Snail
activity, thereby increasing the domain of Slug, Sox9 and also
Snail expression through a positive regulatory loop. Work is
currently underway to specify the hierarchical relationships
between Snail, RhoV and the other neural crest markers during
neural crest development.
Which intracellular targets might be controlled by RhoV
during neural crest specification? Several non-mutually exclu-
sive hypothesis can be proposed. First, like other Rho members,
RhoV might mediate its effects through the direct activation of
kinases, in particular the serine/threonine kinases PAK2 and
JNK (Aronheim et al., 1998). A similar situation was reported
for the Ras-regulated MAPK pathway, which controls the
mesoderm patterning (LaBonne et al., 1995). Second, RhoV
might modify neural crest cell adhesive properties and thereby
change indirectly the intracellular signaling program. This is
consistent with RhoV localization at focal adhesion-like
structures in fibroblastic cells (Aspenstrom et al., 2004).
Along this line, RhoU, the closest RhoV relative, was recentlyshown to control focal adhesion formation and cell migration
through myosin light chain, Akt and JNK (Chuang et al., 2007).
RhoV and RhoU might therefore control similar aspects of cell
adhesion and motility, in consistency with the rescue of RhoV
deficiency by exogenous RhoU (see Fig. 5G) and with the
absence of RhoU expression at early stages of neural crest
differentiation (not shown). Last, RhoV and RhoU display
atypical features, in particular N- and C-terminal extensions and
signals for palmitoylation, whereas other Rho members are
classically farnesylated or geranyl-geranylated (Chenette et al.,
2005). These biochemical properties are likely associated with
specific physiological functions unprecedented in the literature.
Work is underway to identify which cellular functions are
affected by RhoV during early neural crest development, and
which regulatory factors and downstream targets are involved in
these functions.
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